Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1978 Dec;75(12):6240–6242. doi: 10.1073/pnas.75.12.6240

Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.

I Lemaire, R Tseng, S Lemaire
PMCID: PMC393155  PMID: 153530

Abstract

In normal adult rats anesthetized with urethane, intravenous injections of beta-endorphin (30--150 micrograms kg-1) induced a transient fall of blood pressure followed by a small hypertension and a prolonged hypotension. Prior administration of naloxone completely blocked these effects, whereas naloxone, given 1 hr after beta-endorphin, did not reverse the prolonged depressor phase of the opioid peptide. The effects of beta-endorphin on the arterial blood pressure were greatly reduced in animals pretreated with p-chlorophenylalanine, a specific depletor of serotonin. Moreover, in rats pretreated with potent serotonin antagonists such as cyproheptadine, mianserin, and metergoline, beta-endorphin did not produce a significant hypotension. Furthermore, the depressor effect of beta-endorphin was potentiated by fluoxetine, a specific serotonin uptake inhibitor. These observations suggest the participation of a serotonergic pathway in the action of beta-endorphin on the arterial blood pressure.

Full text

PDF
6240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson T. R., Slotkin T. A. p-Chlorophenylalanine-induced enhancement of the effects of morphine on the adrenal medulla. Biochem Pharmacol. 1976 Jul 1;25(13):1547–1548. doi: 10.1016/0006-2952(76)90076-9. [DOI] [PubMed] [Google Scholar]
  2. Beretta C., Ferrini R., Glässer A. H. 1-Methyl-8-beta-carbobenzyloxy-aminomethyl-10-alpha-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature. 1965 Jul 24;207(995):421–422. doi: 10.1038/207421a0. [DOI] [PubMed] [Google Scholar]
  3. Beretta C., Glässer A. H., Nobili M. B., Silvestri R. Antagonism of 5-hydroxytryptamine-induced bronchospasm in guinea-pigs by 8-beta-carbobenzyloxyaminomethyl-1-methyl-10-alpha-ergoline. J Pharm Pharmacol. 1965 Jul;17(7):423–428. doi: 10.1111/j.2042-7158.1965.tb07697.x. [DOI] [PubMed] [Google Scholar]
  4. Bloom F., Segal D., Ling N., Guillemin R. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science. 1976 Nov 5;194(4265):630–632. doi: 10.1126/science.185694. [DOI] [PubMed] [Google Scholar]
  5. Chrétien M., Benjannet S., Dragon N., Seidah N. G., Lis M. Isolation of peptides with opiate activity from sheep and human pituitaries: relationship to beta-lipotropin. Biochem Biophys Res Commun. 1976 Sep 20;72(2):472–478. doi: 10.1016/s0006-291x(76)80066-6. [DOI] [PubMed] [Google Scholar]
  6. Daskalopoulos N. T., Laubie M., Schmitt H. Localization of the central sympatho-inhibitory effect of a narcotic analgesic agent, fentanyl, in cats. Eur J Pharmacol. 1975 Aug;33(1):91–97. doi: 10.1016/0014-2999(75)90142-9. [DOI] [PubMed] [Google Scholar]
  7. Holaday J. W., Law P. Y., Tseng L. F., Loh H. H., Li C. H. beta-Endorphin: pituitary and adrenal glands modulate its action. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4628–4632. doi: 10.1073/pnas.74.10.4628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hosobuchi Y., Meglio M., Adams J. E., Li C. H. beta-Endorphin: development of tolerance and its reversal by 5-hydroxytryptophan in cats. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4017–4019. doi: 10.1073/pnas.74.9.4017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ito A., Schanberg S. M. Central nervous system mechanisms responsible for blood pressure elevation induced by p-chlorophenylalanine. J Pharmacol Exp Ther. 1972 Apr;181(1):65–74. [PubMed] [Google Scholar]
  10. Koe B. K., Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther. 1966 Dec;154(3):499–516. [PubMed] [Google Scholar]
  11. Laubie M., Schmitt H., Canellas J., Roquebert J., Demichel P. Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. Eur J Pharmacol. 1974 Sep;28(1):66–75. doi: 10.1016/0014-2999(74)90113-7. [DOI] [PubMed] [Google Scholar]
  12. Laubie M., Schmitt H., Vincent M., Remond G. Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol. 1977 Nov 1;46(1):67–71. doi: 10.1016/0014-2999(77)90146-7. [DOI] [PubMed] [Google Scholar]
  13. Lemberger L., Rowe H., Carmichael R., Crabtree R., Horng J. S., Bymaster F., Wong D. Fluoxetine, a selective serotonin uptake inhibitor. Clin Pharmacol Ther. 1978 Apr;23(4):421–429. doi: 10.1002/cpt1978234421. [DOI] [PubMed] [Google Scholar]
  14. Li C. H., Chung D., Doneen B. A. Isolation, characterization and opiate activity of beta-endorphin from human pituitary glands. Biochem Biophys Res Commun. 1976 Oct 18;72(4):1542–1547. doi: 10.1016/s0006-291x(76)80189-1. [DOI] [PubMed] [Google Scholar]
  15. Li C. H., Chung D. Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1145–1148. doi: 10.1073/pnas.73.4.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Li C. H., Chung D. Primary structure of human beta-lipotropin. Nature. 1976 Apr 15;260(5552):622–624. doi: 10.1038/260622a0. [DOI] [PubMed] [Google Scholar]
  17. Li C. H., Lemaire S., Yamashiro D., Doneen B. A. The synthesis and opiate activity of beta-endorphin. Biochem Biophys Res Commun. 1976 Jul 12;71(1):19–25. doi: 10.1016/0006-291x(76)90243-6. [DOI] [PubMed] [Google Scholar]
  18. Loh H. H., Tseng L. F., Wei E., Li C. H. beta-endorphin is a potent analgesic agent. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2895–2898. doi: 10.1073/pnas.73.8.2895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. MCCUBBIN J. W., PAGE I. H., SALMOIRAGHI G. C. Cardiovascular and respiratory response to intravenous serotonin in rats. J Pharmacol Exp Ther. 1956 Dec;118(4):477–481. [PubMed] [Google Scholar]
  20. Martin W. R. Opioid antagonists. Pharmacol Rev. 1967 Dec;19(4):463–521. [PubMed] [Google Scholar]
  21. Pontiroli A. E., Viberti G. C., Tognetti A., Pozza G. Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa. Horm Metab Res. 1976 Mar;8(2):106–108. doi: 10.1055/s-0028-1093682. [DOI] [PubMed] [Google Scholar]
  22. Proudfit H. K., Anderson E. G. Morphine analgesia: blockade by raphe magnus lesions. Brain Res. 1975 Nov 21;98(3):612–618. doi: 10.1016/0006-8993(75)90380-7. [DOI] [PubMed] [Google Scholar]
  23. Samanin R., Gumulka W., Valzelli L. Reduced effect of morphine in midbrain raphe lesioned rats. Eur J Pharmacol. 1970;10(3):339–343. doi: 10.1016/0014-2999(70)90205-0. [DOI] [PubMed] [Google Scholar]
  24. Sastry B. S., Phillis J. W. Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortex. Can J Physiol Pharmacol. 1977 Feb;55(1):130–133. doi: 10.1139/y77-020. [DOI] [PubMed] [Google Scholar]
  25. Saxena P. R., van Houwelingen P., Bonta I. L. The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol. 1971;13(3):295–305. doi: 10.1016/0014-2999(71)90218-4. [DOI] [PubMed] [Google Scholar]
  26. Tseng L. F., Loh H. H., Li C. H. Beta-Endorphin as a potent analgesic by intravenous injection. Nature. 1976 Sep 16;263(5574):239–240. doi: 10.1038/263239a0. [DOI] [PubMed] [Google Scholar]
  27. Wong D. T., Horng J. S., Bymaster F. P., Hauser K. L., Molloy B. B. A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci. 1974 Aug 1;15(3):471–479. doi: 10.1016/0024-3205(74)90345-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES